<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347664</id>
  <title nil="true"/>
  <common-name>2-[[4-benzyl-5-[(4-bromophenoxy)methyl]-1,2,4-triazol-3-yl]sulfanyl]-n-naphthalen-1-ylacetamide</common-name>
  <description>2-[[4-benzyl-5-[(4-bromophenoxy)methyl]-1,2,4-triazol-3-yl]sulfanyl]-n-naphthalen-1-ylacetamide is a chemical compound with the formula C28H23BrN4O2S. With an average molecular weight of 559.50 g/mol, 2-[[4-benzyl-5-[(4-bromophenoxy)methyl]-1,2,4-triazol-3-yl]sulfanyl]-n-naphthalen-1-ylacetamide is a heavy molecule.</description>
  <cas>538337-12-1</cas>
  <pubchem-id>3685227</pubchem-id>
  <chemical-formula>C28H23BrN4O2S</chemical-formula>
  <weight>559.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:27:50Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:27:50Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)CN2C(=NN=C2SCC(=O)NC3=CC=CC4=CC=CC=C43)COC5=CC=C(C=C5)Br</moldb-smiles>
  <moldb-formula>C28H23BrN4O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C28H23BrN4O2S/c29-22-13-15-23(16-14-22)35-18-26-31-32-28(33(26)17-20-7-2-1-3-8-20)36-19-27(34)30-25-12-6-10-21-9-4-5-11-24(21)25/h1-16H,17-19H2,(H,30,34)</moldb-inchi>
  <moldb-inchikey>XEMURXGXXDVTBX-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">558.07251</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343557</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[4-benzyl-5-[(4-bromophenoxy)methyl]-1,2,4-triazol-3-yl]sulfanyl]-n-naphthalen-1-ylacetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Naphthalenes</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298002</sync-id>
  <structure-inchikey>XEMURXGXXDVTBX-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000000000800002000800000000000000000000000000000000000000000000000002200104000000002084000000000000000000000000000000000000080000000000000000000000000022000000000100000200800050000000000000210000000000000000000000000400000100000000000000000000000001000000200001800080004000010084080000000100000080000000000000000000000000000000040000081000000000000000490000000000002000000000000000040000000001000100004000000010008000000000000220040000000000008000000005000040000000000400000008010000000000000000000080</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAKAAAAIABBkBoAAAAAwMBBkBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:12Z</structure-indexed-at>
</compound>
